| Dr Harris Salim, MD | |
|
3636 Stockton Hill Rd, Kingman, AZ 86409-0514 | |
| (928) 757-3680 | |
| (928) 757-3614 |
| Full Name | Dr Harris Salim |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 3636 Stockton Hill Rd, Kingman, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144461591 | NPI | - | NPPES |
| 643802 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 45059 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kingman Regional Medical Center | Kingman, AZ | Hospital |
| Entity Name | Aims Physicians And Surgeons |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073699112 PECOS PAC ID: 6709770696 Enrollment ID: O20040211000803 |
News Archive
DURECT Corporation announced today the dosing of the last patient in the U.S. pivotal Phase III clinical study for POSIDUR known as BESST.
American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.
As women age, sexual activity typically declines. But that doesn't necessarily mean they are no longer interested in sex. The problem for many is physical. A new study demonstrates the impact on sexual activity of postmenopausal women as a result of vulvovaginal atrophy and lower urinary tract problems.
Scientists have developed a potent group of potential drug candidates to treat skin cancer, according to a study in the Journal of Medicinal Chemistry today (Thursday).
› Verified 8 days ago
| Entity Name | Salim Medical, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659891786 PECOS PAC ID: 6709156961 Enrollment ID: O20170720000651 |
News Archive
DURECT Corporation announced today the dosing of the last patient in the U.S. pivotal Phase III clinical study for POSIDUR known as BESST.
American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.
As women age, sexual activity typically declines. But that doesn't necessarily mean they are no longer interested in sex. The problem for many is physical. A new study demonstrates the impact on sexual activity of postmenopausal women as a result of vulvovaginal atrophy and lower urinary tract problems.
Scientists have developed a potent group of potential drug candidates to treat skin cancer, according to a study in the Journal of Medicinal Chemistry today (Thursday).
› Verified 8 days ago
| Entity Name | Salim Medical Urgent Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306356738 PECOS PAC ID: 8022376698 Enrollment ID: O20180130000769 |
News Archive
DURECT Corporation announced today the dosing of the last patient in the U.S. pivotal Phase III clinical study for POSIDUR known as BESST.
American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.
As women age, sexual activity typically declines. But that doesn't necessarily mean they are no longer interested in sex. The problem for many is physical. A new study demonstrates the impact on sexual activity of postmenopausal women as a result of vulvovaginal atrophy and lower urinary tract problems.
Scientists have developed a potent group of potential drug candidates to treat skin cancer, according to a study in the Journal of Medicinal Chemistry today (Thursday).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harris Salim, MD 3636 Stockton Hill Rd, Kingman, AZ 86409-0514 Ph: (928) 757-3680 | Dr Harris Salim, MD 3636 Stockton Hill Rd, Kingman, AZ 86409-0514 Ph: (928) 757-3680 |
News Archive
DURECT Corporation announced today the dosing of the last patient in the U.S. pivotal Phase III clinical study for POSIDUR known as BESST.
American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.
As women age, sexual activity typically declines. But that doesn't necessarily mean they are no longer interested in sex. The problem for many is physical. A new study demonstrates the impact on sexual activity of postmenopausal women as a result of vulvovaginal atrophy and lower urinary tract problems.
Scientists have developed a potent group of potential drug candidates to treat skin cancer, according to a study in the Journal of Medicinal Chemistry today (Thursday).
› Verified 8 days ago
Dr. Jeremy Harris Kaplan, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1739 E Beverly Ave Ste 101, Kingman, AZ 86409 Phone: 928-681-8715 | |
Deborah K Luckie, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3269 Stockton Hill Rd, Hospitalist Dept., Kingman, AZ 86409 Phone: 928-681-8577 | |
Dr. Ordessia Charran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1739 E Beverly Ave Ste 203, Kingman, AZ 86409 Phone: 928-757-3133 Fax: 928-757-3136 | |
Dr. Tiffany E Russell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1510 N Stockton Hill Rd, Kingman, AZ 86401 Phone: 928-753-1177 | |
Narayanaswamy Deepak, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1753 Airway Ave, Suite A, Kingman, AZ 86409 Phone: 928-757-4359 | |
Dr. S Ismail Ah Bokhari Sr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1720 E Beverly Ave, Suite B, Kingman, AZ 86409 Phone: 928-757-1333 Fax: 928-757-2367 |